Showing 1 - 3 results of 3 for search 'Amir Faour', query time: 0.02s Refine Results
  1. 1
    Reperfusion After Fibrinolytic Therapy (RAFT): An open-label, multi-centre, randomised controlled trial of bivalirudin versus heparin in rescue percutaneous coronary intervention.

    Reperfusion After Fibrinolytic Therapy (RAFT): An open-label, multi-centre, randomised controlled trial of bivalirudin versus heparin in rescue percutaneous coronary intervention. by Amir Faour, Nicholas Collins, Trent Williams, Arshad Khan, Craig P Juergens, Sidney Lo, Darren L Walters, Derek P Chew, John K French

    Published 2021-01-01
    Get full text
    Article
  2. 2
    Reperfusion After Fibrinolytic Therapy (RAFT): An open-label, multi-centre, randomised controlled trial of bivalirudin versus heparin in rescue percutaneous coronary intervention

    Reperfusion After Fibrinolytic Therapy (RAFT): An open-label, multi-centre, randomised controlled trial of bivalirudin versus heparin in rescue percutaneous coronary intervention by Amir Faour, Nicholas Collins, Trent Williams, Arshad Khan, Craig P. Juergens, Sidney Lo, Darren L. Walters, Derek P. Chew, John K. French

    Published 2021-01-01
    Get full text
    Article
  3. 3
    Late Outcomes of Patients With Prehospital ST‐Segment Elevation and Appropriate Cardiac Catheterization Laboratory Nonactivation

    Late Outcomes of Patients With Prehospital ST‐Segment Elevation and Appropriate Cardiac Catheterization Laboratory Nonactivation by Amir Faour, Reece Pahn, Callum Cherrett, Oliver Gibbs, Karen Lintern, Christian J. Mussap, Rohan Rajaratnam, Dominic Y. Leung, David A. Taylor, Steven C. Faddy, Sidney Lo, Craig P. Juergens, John K. French

    Published 2022-07-01
    Get full text
    Article

Search Tools: